Author(s): Morin CM; Vézina-Im LA; Chen SJ; Ivers H; Carney CE; Chaput JP; Dang-Vu TT; Davidson JR; Belleville G; Lorrain D; Horn O; Robillard R; ...
Objectives: To estimate the prevalence of insomnia and the use of sleep aids among Canadian adults. Methods: Data were derived from a phone interview conducted (April to October 2023) with a strat ...
Article GUID: 39369578
Author(s): Garneau J; Savard J; Dang-Vu TT; Gouin JP;
Objective: This study examined whether high frequency heart-rate variability (HF-HRV) and HF-HRV reactivity to worry moderate response to cognitive behavioural therapy for insomnia (CBT-I) within both a standard and stepped-care framework among cancer patie ...
Article GUID: 38991424
Author(s): Dang-Vu TT; Salimi A; Boucetta S; Wenzel K; O' Byrne J; Brandewinder M; Berthomier C; Gouin JP; ...
Background and aim: Predisposing factors place certain individuals at higher risk for insomnia, especially in the presence of precipitating conditions such as stressful life events. Sleep spindles ...
Article GUID: 25713529
Author(s): Gouin JP; Wenzel K; Boucetta S; O' Byrne J; Salimi A; Dang-Vu TT;
Objective: The aim of this study was to evaluate whether high-frequency heart rate variability (HF-HRV) during waking restfulness and during worry predicts increases in sleep disturbances in response to a stressful life event. Methods: A longitudinal study ...
Article GUID: 25819418
Author(s): Arnold V; Ancoli-Israel S; Dang-Vu TT; Mishima K; Pinner K; Malhotra M; Moline M;
Background: Pharmacologic treatments are available to treat insomnia, a common and burdensome sleep disorder, but may be contraindicated in older adults who are prone to side effects from sleep-promoting drugs. These analyses of sleep diary data from Study ...
Article GUID: 38748321
Author(s): Maltezos A; Perrault AA; Walsh NA; Phillips EM; Gong K; Tarelli L; Smith D; Cross NE; Pomares FB; Gouin JP; Dang-Vu TT; ...
Study objective: To provide a comprehensive assessment of sleep state misperception in insomnia disorder (INS) and good sleepers (GS) by comparing recordings performed for one night in-lab (PSG and ...
Article GUID: 38325157
Author(s): Chaput JP; Janssen I; Sampasa-Kanyinga H; Carney CE; Dang-Vu TT; Davidson JR; Robillard R; Morin CM; ...
Objective: To estimate health care and productivity costs associated with insomnia symptoms in Canadian adults. Methods: Three pieces of information were needed to calculate estimates based on a p ...
Article GUID: 36319579
Author(s): Zhao JL; Cross N; Yao CW; Carrier J; Postuma RB; Gosselin N; Kakinami L; Dang-Vu TT;
Study objectives: To examine the longitudinal association between probable insomnia status and both subjective and objective memory decline in middle-aged and older adults. Methods: 26 363 participants, =45 years, completed baseline and follow-up (3 years ...
Article GUID: 35877203
Author(s): C Moderie
CONCLUSION: Multiple and sustained nonpharmacological approaches are recommended for the treatment of sleep disturbances in patients with neurocognitive disorder. Pharmacological indications remain limited, and further randomized clinical trials integrating ...
Article GUID: 34916075
Author(s): Yao CW; Pelletier A; Fereshtehnejad SM; Cross N; Dang-Vu T; Postuma RB;
Study objectives: To identify the association between insomnia symptoms and signs of prodromal neurodegeneration, including an analysis of potential differences between sleep-onset and sleep-maintenance insomnia. Methods: We included those aged 45-85 years ...
Article GUID: 34314348
Author(s): Machado FV, Louzada LL, Cross NE, Camargos EF, Dang-Vu TT, Nóbrega OT
Exp Gerontol. 2020 Apr 30;:110962 Authors: Machado FV, Louzada LL, Cross NE, Camargos EF, Dang-Vu TT, Nóbrega OT
Article GUID: 32360985
- Page 1 / 2 >